These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 2893663

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. c-erbB-2 amplification in node-negative human breast cancer.
    Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6941-4. PubMed ID: 2573424
    [Abstract] [Full Text] [Related]

  • 5. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E.
    Cancer Res; 1989 Dec 01; 49(23):6675-9. PubMed ID: 2573420
    [Abstract] [Full Text] [Related]

  • 6. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ, Jordan PA, Huper G, Marks JR, Iglehart JD, Layfied LJ.
    Mod Pathol; 1993 Nov 01; 6(6):673-8. PubMed ID: 7905629
    [Abstract] [Full Text] [Related]

  • 7. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ, Frierson HF, Williams ME.
    Mod Pathol; 1993 Nov 01; 6(6):654-9. PubMed ID: 7905628
    [Abstract] [Full Text] [Related]

  • 8. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
    Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR.
    Cancer Res; 1990 Oct 15; 50(20):6701-7. PubMed ID: 2208136
    [Abstract] [Full Text] [Related]

  • 9. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
    Wright C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH.
    Cancer Res; 1989 Apr 15; 49(8):2087-90. PubMed ID: 2564806
    [Abstract] [Full Text] [Related]

  • 10. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E, Smith K, Bromley L, LeJeune S, Greenall M, Lane D, Harris AL.
    Oncogene; 1991 Dec 15; 6(12):2277-84. PubMed ID: 1685017
    [Abstract] [Full Text] [Related]

  • 11. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA, Senior PV, Jones JL, Critchley DR, Varley JM.
    J Pathol; 1989 Jun 15; 158(2):97-105. PubMed ID: 2569035
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
    Freeman JW, McGrath P, Bondada V, Selliah N, Ownby H, Maloney T, Busch RK, Busch H.
    Cancer Res; 1991 Apr 15; 51(8):1973-8. PubMed ID: 1672621
    [Abstract] [Full Text] [Related]

  • 13. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
    Giai M, Roagna R, Ponzone R, De Bortoli M, Dati C, Sismondi P.
    Anticancer Res; 1994 Apr 15; 14(3B):1441-50. PubMed ID: 7915096
    [Abstract] [Full Text] [Related]

  • 14. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
    Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP.
    Anticancer Res; 1992 Apr 15; 12(2):419-25. PubMed ID: 1349794
    [Abstract] [Full Text] [Related]

  • 15. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
    Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL.
    Cancer Res; 1990 Jul 15; 50(14):4332-7. PubMed ID: 1973070
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Jul 15; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 17. Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma.
    Ali IU, Campbell G, Lidereau R, Callahan R.
    Oncogene Res; 1988 Sep 15; 3(2):139-46. PubMed ID: 3226722
    [Abstract] [Full Text] [Related]

  • 18. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
    Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J.
    Cancer Res; 1989 Jun 01; 49(11):3104-8. PubMed ID: 2566377
    [Abstract] [Full Text] [Related]

  • 19. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP, Kacinski B, Validire P, Beuvon F, Sastre X, Benoit P, dela Rochefordière A, Mosseri V, Pouillart P, Scholl S.
    J Cell Biochem; 1990 Nov 01; 44(3):189-98. PubMed ID: 1980125
    [Abstract] [Full Text] [Related]

  • 20. [Preliminary studies on c-erbB-2 protooncogene in breast cancer].
    He LW.
    Zhonghua Zhong Liu Za Zhi; 1992 May 01; 14(3):171-4. PubMed ID: 1356719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.